refractory AML

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer . refractory anemia . refractory multiple myeloma / Amling . aml . AMLS . Amler . Aml : acute myeloid leukemia AML . money laundering AML . Money Laundering AML . acute myelogenous leukemia AML . Acute Myeloid Leukemia AML * relapsed refractory AML *

Related by context. Frequent words. (Click for all words.) 76 relapsed refractory multiple myeloma 74 refractory multiple myeloma 70 metastatic renal cell carcinoma 69 HER2 positive metastatic breast 69 dacarbazine 68 refractory Hodgkin lymphoma 68 vandetanib 67 unresectable 67 relapsed multiple myeloma 67 HGS ETR1 67 FOLFIRI 67 refractory PTCL 66 glioblastoma multiforme GBM 66 axitinib 66 Trastuzumab 65 diabetic neuropathic pain 65 castration resistant prostate cancer 65 BAY #-# 65 Taxotere ® 65 medullary thyroid cancer 64 IMC A# 64 neoadjuvant chemotherapy 64 cutaneous T cell 64 myelofibrosis 64 peginterferon 64 plus prednisone 64 lupus nephritis 64 Bortezomib 64 CA4P 64 Lenalidomide 64 Telcyta 64 azacitidine 64 methotrexate MTX 64 neoadjuvant 64 temsirolimus 64 Combination therapy 64 nab paclitaxel 64 Jevtana 64 limiting toxicity 64 epirubicin 64 allogeneic stem cell 64 interferon alfa 64 decitabine 64 bortezomib 63 ocrelizumab 63 relapsed refractory 63 TORISEL 63 tocilizumab 63 monotherapy 63 chemoradiation 63 vinorelbine 63 plus gemcitabine 63 sunitinib 63 biologic therapy 63 octreotide 63 cytarabine 63 hepatocellular carcinoma HCC 63 PXD# 63 lymphoma CTCL 63 cytotoxic chemotherapy 63 adalimumab 63 dasatinib 63 peginterferon alfa 2b 63 mitoxantrone 63 secondary efficacy endpoints 63 NRTI 62 Phase 2a trial 62 docetaxel 62 elagolix 62 chronic lymphocytic leukemia CLL 62 romidepsin 62 topotecan 62 TELCYTA 62 Erlotinib 62 transcriptase inhibitor NNRTI 62 cytogenetic response 62 IMGN# 62 Ph + ALL 62 SUTENT 62 Acute Myeloid Leukemia AML 62 talactoferrin 62 mCRC 62 chronic myeloid leukemia CML 62 ThermoDox ® 61 nilotinib 61 evaluable 61 fludarabine 61 Azixa 61 Nexavar ® 61 metastatic melanoma 61 tipranavir 61 mixed dyslipidemia 61 hepatitis C HCV 61 evaluable patients 61 phase IIa 61 androgen independent 61 liver metastases 61 FOLFOX 61 sorafenib 61 sapacitabine 61 hypercalcemia

Back to home page